- Home
- TFIN vs MNKD Comparison
TFIN vs MNKD Comparison
Compare TFIN & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TFIN
- MNKD
- Stock Information
- Founded
- TFIN 1981
- MNKD 1991
- Country
- TFIN United States
- MNKD United States
- Employees
- TFIN N/A
- MNKD N/A
- Industry
- TFIN Major Banks
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- TFIN Finance
- MNKD Health Care
- Exchange
- TFIN Nasdaq
- MNKD Nasdaq
- Market Cap
- TFIN 1.3B
- MNKD 1.4B
- IPO Year
- TFIN N/A
- MNKD 2004
- Fundamental
- Price
- TFIN $57.77
- MNKD $4.15
- Analyst Decision
- TFIN Hold
- MNKD Strong Buy
- Analyst Count
- TFIN 6
- MNKD 5
- Target Price
- TFIN $68.50
- MNKD $9.40
- AVG Volume (30 Days)
- TFIN 220.0K
- MNKD 1.9M
- Earning Date
- TFIN 07-16-2025
- MNKD 05-08-2025
- Dividend Yield
- TFIN N/A
- MNKD N/A
- EPS Growth
- TFIN N/A
- MNKD 228.27
- EPS
- TFIN 0.37
- MNKD 0.10
- Revenue
- TFIN $401,390,000.00
- MNKD $297,595,000.00
- Revenue This Year
- TFIN $12.09
- MNKD $14.36
- Revenue Next Year
- TFIN $14.37
- MNKD $13.36
- P/E Ratio
- TFIN $155.12
- MNKD $40.01
- Revenue Growth
- TFIN 0.68
- MNKD 32.50
- 52 Week Low
- TFIN $42.90
- MNKD $4.05
- 52 Week High
- TFIN $110.58
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- TFIN 50.31
- MNKD 37.04
- Support Level
- TFIN $52.77
- MNKD $4.07
- Resistance Level
- TFIN $61.11
- MNKD $4.25
- Average True Range (ATR)
- TFIN 2.57
- MNKD 0.16
- MACD
- TFIN -0.26
- MNKD -0.03
- Stochastic Oscillator
- TFIN 47.44
- MNKD 12.82
About TFIN Triumph Financial Inc.
Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.